Japanese Abel Prize laureate: Creativity is key in mathematics
A Japanese mathematician who won the prestigious Abel Prize has stressed the importance of creativity in research.
Kyoto University Program-Specific Professor Kashiwara Masaki attended the award ceremony in Oslo, Norway, on Tuesday.
In a video shown at the start of the ceremony, the professor talked about when he first found mathematics interesting and explained that he still writes formulas by hand.
He then took to the stage and received a glass plaque from King Harald of Norway.
Kashiwara is the first Japanese laureate of the prize created by the Norwegian government. It is sometimes called the "Nobel Prize for mathematics."
He has been recognized for "his fundamental contributions to algebraic analysis and representation theory, in particular the development of the theory of D-modules."
In a speech, Kashiwara said he is honored to receive the prize, which is "a great recognition of my entire research spanning more than 50 years."
He mentioned his late mentor Sato Mikio and said: "He taught me how important it is to create new things in mathematics. This becomes a valuable guide in my research career."
He concluded the speech with a gratitude for his fellow researchers and his wife, saying that "they have allowed me to devote myself to mathematics and eventually brought the Abel Prize."
The organizers say he is the first laureate working outside the European Union and the United States since the prize was created in 2002.
They also expressed hope the prize will continue to inspire Japanese, Asian and worldwide mathematicians.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Mainichi
03-06-2025
- The Mainichi
Final phase of trial for Parkinson's drug to treat Alzheimer's begins in Japan
KYOTO (Kyodo) -- The final phase of a clinical trial aiming to treat familial Alzheimer's disease using existing medication for Parkinson's disease has been in progress since May, a Japanese research institute involved in the project said Tuesday. Led by drugmaker Towa Pharmaceutical Co. and Kyoto University's Center for iPS Cell Research and Application, the project utilizes induced pluripotent stem cells to identify effective treatments, known as "iPS drug discovery." The clinical trial being conducted until March 2028 using bromocriptine, a drug used to treat Parkinson's, at several medical institutions including Mie University Hospital aims to enroll 24 patients suffering from familial Alzheimer's disease who carry mutations of a specific gene, with half of them receiving a placebo. Alzheimer's is a type of dementia that causes problems with memory and other cognitive abilities serious enough to interfere with daily life. Medicine can temporarily slow progress of the symptoms but at present there is no treatment to completely cure the disease. Familial Alzheimer's disease, also known as early-onset familial Alzheimer's disease, is a rare form of the condition generally affecting individuals below the age of 60.
29-05-2025
Okinawan Remains Looted in Early Showa Era Returned by Kyoto Univ.
News from Japan Society May 29, 2025 19:20 (JST) Kyoto, May 29 (Jiji Press)--Remains taken by Japanese researchers from a tomb in the southernmost prefecture of Okinawa in the early 20th century have been returned, it was learned Thursday. Researchers from Kyoto Imperial University, which is now Kyoto University, had taken the remains early in the country's Showa era (1926-1989) from the "Mumujanabaka" tomb built in the middle ages in the Okinawan village of Nakijin. The remains, stored in 15 container boxes, were delivered to the Nakijin board of education on May 21. The board, which is set to preserve the remains as academic materials, said it was told by Kyoto University that the remains were of at least 26 people. An assistant professor and lecturer from Kyoto Imperial University are believed to have taken the remains from Mumujanabaka, according to the board. The descendants of those in the tomb filed a lawsuit in 2018 demanding that Kyoto University return the remains. Kyoto District Court and Osaka High Court rejected the demand but called on relevant organizations to hold discussions to resolve the issue. [Copyright The Jiji Press, Ltd.] Jiji Press
Japan Times
29-05-2025
- Japan Times
Team develops esophageal cancer prediction method using the inside of the cheek
A team of Kyoto University and other researchers has developed a method of predicting with high accuracy the risk of someone developing esophageal cancer by analyzing cells collected from inside the person's cheeks. If brought into practical use, the method could facilitate early cancer detection and cancer prevention through lifestyle improvements. The team's findings were published in an online international medical journal in April. Its study covered 222 people age 40-94, all with a history of smoking and drinking who either had esophageal cancer or did not. The team swabbed the inside of their cheeks to extract cheek mucosa cells and analyzed any genetic mutations. Participants with a lower tolerance for alcohol had more genetic mutations in their extracted cells when their alcoholic intake increased. On the other hand, those whose bodies were capable of processing alcohol well did not display such an increase. The team also found that esophageal cancer patients had more genetic mutations than those who did not, even if their cancer was discovered at an early stage. The team managed to make cancer probability predictions with an accuracy of over 70% by analyzing various genetic mutation data together. The team found "what is believed to be a biomarker that indicates (cancer) risks more objectively and accurately than with the conventional method of interviewing (patients) on their lifestyle habits and predispositions," said team member Akira Yokoyama, lecturer at Kyoto University Hospital.
